| Are elevated homocysteine levels at 24-28 weeks of gestation risk factors for preeclampsia and intrauterine growth restriction | Ebru TARIM,Esra KILIÇDAĞ,Tayfun BAĞIŞ,Erdoğan ASLAN,Serkan ERKANLI,ERHAN ŞİMŞEK,Esra KUŞÇU | 4–6 |
| Abnormal foetal heart rate pattern and their relationship to amniotic fluid erythropoietin levels | Önder ÇELİK,Şeyma HASÇALIK,Alanur GÜVEN,Fahri TURHAN,Saim YOLOĞLU | 7–9 |
| Transvaginal versus transperineal ultrasonographic examination of the cervix at 15-32 weeks of gestation: A blinded comparison | Oluş APİ,Orhan ÜNAL,Mustafa ALTUNDAĞ,MURAT APİ,Birol CENGİZOĞLU,Cem TURAN | 10–13 |
| Breech presentation in nulliparous women: An evaluation of 288 cases | Serdar DİLBAZ,Orhan GELİŞEN,Güvendağ E. Seda GÜVEN,Berna DİLBAZ,Orkun TAN,Bekir KATAŞ | 14–16 |
| Pregnancy satisfaction for antenatal care | Esra SAATÇİ,Volkan ARPACI,Nafiz BOZDEMİR,Güney ERGUN,ERSİN AKPINAR,Cüneyt EVRÜKE | 17–22 |
| Maternal mortality rate in a referral center in Turkey; 1996-2001 | Özbey Berna DİLBAZ,Eray ÇALIŞKAN,Nilgün ÖZTÜRK,Ali HABERAL | 23–26 |
| Maternal creatine kinase is not a reliable diagnostic marker for ectopic pregnancy | Mesut KAYMAN,F. Suat DEDE,İlhan ARSLANPENÇE,Hülya DEDE,Orhan GELİŞEN | 27–30 |
| Two different regimens of intravaginal plus oral and intravaginal misoprostol for termination of second trimester pathologic pregnancies | C. Eftal TANER,ÜMİT ARSLAN NAYKI,Afet EGE,Tolga MIZRAK | 31–33 |
| Plasma renin activity in diagnosis of polycystic ovarian syndrome | Ayşe GÜRBÜZ,Ateş KARATEKE,Nurettin SERİNKAN,Canan KABACA,Zeki ŞAHİNOĞLU | 34–36 |
| A comparison of the use of the microdose flare-up ovarian hyperstimulation protocol in IVF patients with diminished ovarian reserve and in patients with previous IVF failure with long protocol regimens of GnRh agonist | Mustafa UĞUR,MURAT EKİN,Ayça IŞIK | 37–39 |
| Sperm retrieval and IVF-ICSI results in the treatment of obstructive and non-obstructive azoospermia | Talat YURDAKUL,HÜSEYİN GÖRKEMLİ,Murad AKTAN,Selçuk DUMAN,Selçuk GÜVEN |